Insider Trading History of Frohlich Tom

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Frohlich Tom since 2021. This trader's CIK number is 1823925. At the time of last reporting, Frohlich Tom was the Chief Executive Officer of Jade Biosciences, Inc.. (stock ticker symbol JBIO). Also see all insider trading activities at Jade Biosciences, Inc..

Note that in the past Frohlich Tom also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Chinook Therapeutics, Inc. (KDNY) by Frohlich Tom

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 KDNY 0 $0 8,266 $200,569 15,136 $0
2022 KDNY 0 $0 11,095 $192,520 20,383 $0
2021 KDNY 0 $0 60,000 $845,372 48,580 $14,700

Yearly summary of insider trading at Jade Biosciences, Inc. (JBIO) by Frohlich Tom

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 JBIO 6,000 $44,400 0 $0 0 $0


Insider trading activities at 2 companies by Frohlich Tom:

1. Chinook Therapeutics, Inc. (KDNY)

2. Jade Biosciences, Inc. (JBIO)

Table 1. Insider trading of Chinook Therapeutics, Inc. (KDNY) by Frohlich Tom

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-02-10 KDNY Option Ex 6,803 .00 0
2023-02-10 KDNY Sale 3,700 23.75 87,871
2023-01-31 KDNY Option Ex 8,333 .00 0
2023-01-31 KDNY Sale 4,566 24.68 112,698
2022-10-06 KDNY Sale 7,360 19.69 144,933
2022-10-06 KDNY Option Ex 13,582 .00 0
2022-02-10 KDNY Option Ex 6,801 .00 0
2022-02-11 KDNY Sale 3,735 12.74 47,587
2021-11-10 KDNY Sale 6,230 15.48 96,440
2021-11-05 KDNY Option Ex 15,000 .42 6,300
2021-11-05 KDNY Sale 20,000 14.00 280,000
2021-11-08 KDNY Sale 13,770 15.17 208,932
2021-10-06 KDNY Option Ex 13,580 .00 0
2021-09-24 KDNY Option Ex 20,000 .42 8,400
2021-09-24 KDNY Sale 20,000 13.00 260,000

Table 2. Insider trading of Jade Biosciences, Inc. (JBIO) by Frohlich Tom

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-05-16 JBIO Buy 6,000 7.40 44,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Frohlich Tom (Chief Executive Officer of Jade Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.